Selective Suppression of Cell Growth and Programmed Cell Death-Ligand 1 Expression in HT1080 Fibrosarcoma Cells by Low Molecular Weight Fucoidan Extract
出版年份 2019 全文链接
标题
Selective Suppression of Cell Growth and Programmed Cell Death-Ligand 1 Expression in HT1080 Fibrosarcoma Cells by Low Molecular Weight Fucoidan Extract
作者
关键词
-
出版物
Marine Drugs
Volume 17, Issue 7, Pages 421
出版商
MDPI AG
发表日期
2019-07-22
DOI
10.3390/md17070421
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Immune checkpoint inhibitors in epidermal growth factor receptor mutant non-small cell lung cancer: Current controversies and future directions
- (2018) Ross A. Soo et al. LUNG CANCER
- Combination Immunotherapy in Non-small Cell Lung Cancer
- (2018) Melina E. Marmarelis et al. Current Oncology Reports
- RhoB: Team Oncogene or Team Tumor Suppressor?
- (2018) Julia Ju et al. Genes
- Structural elucidation of fucoidan from Cladosiphon okamuranus (Okinawa mozuku)
- (2018) Seng Joe Lim et al. FOOD CHEMISTRY
- Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA
- (2017) Matthew A. Coelho et al. IMMUNITY
- An Exploratory Study on the Anti-inflammatory Effects of Fucoidan in Relation to Quality of Life in Advanced Cancer Patients
- (2017) Hidenori Takahashi et al. INTEGRATIVE CANCER THERAPIES
- Cytotoxic Effects of Sarcophyton sp. Soft Corals—Is There a Correlation to Their NMR Fingerprints?
- (2017) Mohamed Farag et al. Marine Drugs
- Effects of Low-Molecular-Weight Fucoidan and High Stability Fucoxanthin on Glucose Homeostasis, Lipid Metabolism, and Liver Function in a Mouse Model of Type II Diabetes
- (2017) Hong-Ting Lin et al. Marine Drugs
- The mechanisms tumor cells utilize to evade the host's immune system
- (2017) Nyanbol Kuol et al. MATURITAS
- Induction of PD-L1 expression by epidermal growth factor receptor–mediated signaling in esophageal squamous cell carcinoma
- (2017) Wencheng Zhang et al. OncoTargets and Therapy
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
- (2017) Hashem O. Alsaab et al. Frontiers in Pharmacology
- Inhibition of Influenza A Virus Infection by Fucoidan Targeting Viral Neuraminidase and Cellular EGFR Pathway
- (2017) Wei Wang et al. Scientific Reports
- Oligo-Fucoidan prevents IL-6 and CCL2 production and cooperates with p53 to suppress ATM signaling and tumor progression
- (2017) Li-Mei Chen et al. Scientific Reports
- Effects of different ligands on epidermal growth factor receptor (EGFR) nuclear translocation
- (2016) Jerusa A.Q.A. Faria et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Key Role of Sulfation and Branching on Fucoidan Antitumor Activity
- (2016) Catarina Oliveira et al. MACROMOLECULAR BIOSCIENCE
- The Oligo Fucoidan Inhibits Platelet-Derived Growth Factor-Stimulated Proliferation of Airway Smooth Muscle Cells
- (2016) Chao-Huei Yang et al. Marine Drugs
- Toxicological Evaluation of Low Molecular Weight Fucoidan in Vitro and in Vivo
- (2016) Pai-An Hwang et al. Marine Drugs
- Antithrombotic activity of oral administered low molecular weight fucoidan from Laminaria Japonica
- (2016) Xue Zhao et al. THROMBOSIS RESEARCH
- PD-1 and its ligands are important immune checkpoints in cancer
- (2016) Yinan Dong et al. Oncotarget
- Regulation of PD-L1: a novel role of pro-survival signalling in cancer
- (2015) J. Chen et al. ANNALS OF ONCOLOGY
- EGFR-TKI down-regulates PD-L1 in EGFR mutant NSCLC through inhibiting NF-κB
- (2015) Kailong Lin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma
- (2015) Kathleen M. Mahoney et al. CLINICAL THERAPEUTICS
- A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G
- (2015) Edgardo D. Carosella et al. EUROPEAN UROLOGY
- Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation
- (2015) Nan Chen et al. Journal of Thoracic Oncology
- Fucoidan from Macrocystis pyrifera Has Powerful Immune-Modulatory Effects Compared to Three Other Fucoidans
- (2015) Wei Zhang et al. Marine Drugs
- Fucoidan and Cancer: A Multifunctional Molecule with Anti-Tumor Potential
- (2015) Farzaneh Atashrazm et al. Marine Drugs
- Low Molecular Weight Fucoidan Inhibits Tumor Angiogenesis through Downregulation of HIF-1/VEGF Signaling under Hypoxia
- (2015) Meng-Chuan Chen et al. Marine Drugs
- PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
- (2015) S. P. Patel et al. MOLECULAR CANCER THERAPEUTICS
- Systematic synthesis of low-molecular weight fucoidan derivatives and their effect on cancer cells
- (2015) Akihiro Kasai et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Upregulation of PD-L1 by EML4-ALK fusion protein mediates the immune escape in ALK positive NSCLC: Implication for optional anti-PD-1/PD-L1 immune therapy for ALK-TKIs sensitive and resistant NSCLC patients
- (2015) Shaodong Hong et al. OncoImmunology
- Cell-death assessment by fluorescent and nonfluorescent cytosolic and nuclear staining techniques
- (2014) N. ATALE et al. JOURNAL OF MICROSCOPY
- Intestinal Absorption of Fucoidan Extracted from the Brown Seaweed, Cladosiphon okamuranus
- (2014) Takeaki Nagamine et al. Marine Drugs
- PD-L1 Expression Is Increased in a Subset of Basal Type Breast Cancer Cells
- (2014) Hatem Soliman et al. PLoS One
- Targeting the RAS oncogene
- (2013) Asami Takashima et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Brown seaweed fucoidan: Biological activity and apoptosis, growth signaling mechanism in cancer
- (2013) Kalimuthu Senthilkumar et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- RhoA, RhoB and RhoC have different roles in cancer cell migration
- (2013) A.J. RIDLEY JOURNAL OF MICROSCOPY
- Cytotoxic Effects of Fucoidan Nanoparticles against Osteosarcoma
- (2013) Ryuichiro Kimura et al. Marine Drugs
- Fucoidan Extract Enhances the Anti-Cancer Activity of Chemotherapeutic Agents in MDA-MB-231 and MCF-7 Breast Cancer Cells
- (2013) Zhongyuan Zhang et al. Marine Drugs
- Downregulation of the GnT-V gene inhibits metastasis and invasion of BGC823 gastric cancer cells
- (2013) BINBIN HUANG et al. ONCOLOGY REPORTS
- Targeting Androgen Receptor/Src Complex Impairs the Aggressive Phenotype of Human Fibrosarcoma Cells
- (2013) Gabriella Castoria et al. PLoS One
- Flow cytometry: retrospective, fundamentals and recent instrumentation
- (2012) Julien Picot et al. CYTOTECHNOLOGY
- Structural Analysis of a Heteropolysaccharide from Saccharina japonica by Electrospray Mass Spectrometry in Tandem with Collision-Induced Dissociation Tandem Mass Spectrometry (ESI-CID-MS/MS)
- (2012) Weihua Jin et al. Marine Drugs
- Effects of Oral Administration of Fucoidan Extracted from Cladosiphon okamuranus on Tumor Growth and Survival Time in a Tumor-Bearing Mouse Model
- (2012) Kazuo Azuma et al. Marine Drugs
- The tumor suppressor RECK interferes with HER-2/Neu dimerization and attenuates its oncogenic signaling
- (2011) Kun-Jing Hong et al. FEBS LETTERS
- Fucoidan from Undaria pinnatifida Induces Apoptosis in A549 Human Lung Carcinoma Cells
- (2011) Hye-Jin Boo et al. PHYTOTHERAPY RESEARCH
- Fucoidan Extract Induces Apoptosis in MCF-7 Cells via a Mechanism Involving the ROS-Dependent JNK Activation and Mitochondria-Mediated Pathways
- (2011) Zhongyuan Zhang et al. PLoS One
- Emerging importance of ALK in neuroblastoma
- (2011) Anna M. Azarova et al. SEMINARS IN CANCER BIOLOGY
- Fucoidan reduces the toxicities of chemotherapy for patients with unresectable advanced or recurrent colorectal cancer
- (2011) MASAHIDE IKEGUCHI et al. Oncology Letters
- Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma
- (2010) Ryosuke Hino et al. CANCER
- Tumor Vascular Changes Mediated by Inhibition of Oncogenic Signaling
- (2009) N. Qayum et al. CANCER RESEARCH
- Functionalin vivooptical imaging of tumor angiogenesis, growth, and metastasis prevented by administration of anti-human VEGF antibody in xenograft model of human fibrosarcoma HT1080 cells
- (2009) Aki Hanyu et al. CANCER SCIENCE
- Novel Therapeutic Inhibitors of the c-Met Signaling Pathway in Cancer
- (2009) J. P. Eder et al. CLINICAL CANCER RESEARCH
- Fucoidan Induces Apoptosis through Activation of Caspase-8 on Human Breast Cancer MCF-7 Cells
- (2009) Yumi Yamasaki-Miyamoto et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Combined therapies for cancer: a review of EGFR-targeted monotherapy and combination treatment with other drugs
- (2009) Beata Zahorowska et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- Epidermal Growth Factor Receptor Blockade in Combination with Conventional Chemotherapy Inhibits Soft Tissue Sarcoma Cell Growth In vitro and In vivo
- (2008) W. Ren et al. CLINICAL CANCER RESEARCH
- Inhibitory effects of fucoidan on activation of epidermal growth factor receptor and cell transformation in JB6 Cl41 cells
- (2008) Na Yeon Lee et al. FOOD AND CHEMICAL TOXICOLOGY
- Effects of molecular weight and hydrolysis conditions on anticancer activity of fucoidans from sporophyll of Undaria pinnatifida
- (2008) Chen Yang et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Fucoidan fromLaminaria cichorioidesinhibits AP‐1 transactivation and cell transformation in the mouse epidermal JB6 cells
- (2008) Na Yeon Lee et al. MOLECULAR CARCINOGENESIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started